申请人:NEOCAGE SL
公开号:US11534449B2
公开(公告)日:2022-12-27
Provided are compositions and methods for treatment of cancer and for adoptive T cell therapy (ACT). The compositions comprise one or more derivatives of tricin 7-O-β-D-glucopyranoside (ANTARTINA®). The compositions comprise one or more pharmaceutically acceptable excipients convenient for delivery of the tricin 7-O-β-D-glucopyranoside derivatives. Tricin 7-O-β-D-glucopyranoside derivatives described herein include acetylated tricin 7-O-β-D-glucopyranoside, as well as glucose, maltose, cellobiose, lactose, xylose, and galactose derivatives. The methods include treatment, or reduction in the risk of suffering from, colorectal cancer and hepatocellular cancer.
本文提供了用于治疗癌症和采用性 T 细胞疗法 (ACT) 的组合物和方法。这些组合物包括一种或多种三尖杉素 7-O-β-D-吡喃葡萄糖苷(ANTARTINA®)的衍生物。组合物包含一种或多种药学上可接受的赋形剂,便于三尖杉素 7-O-β-D-Glucopyranoside 衍生物的给药。本文所述的三尖杉素 7-O-β-D-吡喃葡萄糖苷衍生物包括乙酰化三尖杉素 7-O-β-D-吡喃葡萄糖苷,以及葡萄糖、麦芽糖、纤维生物糖、乳糖、木糖和半乳糖衍生物。这些方法包括治疗结肠直肠癌和肝细胞癌或降低其患病风险。